Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
NCT Number: NCT03887091
This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Research has shown that many clinical trial participants are confused about clinical trials. Common participant misunderstandings include the idea of randomization, benefits to participants' health, the proven nature of the study intervention, and failure to recognize the primary purpose of the trial. There can sometimes be unintended miscommunication between the study doctor and/or nursing staff and participants. Thus, there is a clear need to identify ways to improve communication during clinical trials. The investigator's current culture of web-based information presentation, whether it takes the form of PowerPoint presentations, videos, websites, or audio tools, suggests that adding such technology to the cancer research realm may improve a participant's clinical trial experience and possibly improve participant understanding and safety while enrolled on a clinical trial. Video and web-based tools in cancer research have the potential to transform clinical trial practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Postwire© is a web-based, video platform
Time frame: 168 Days
Wilcoxon Rank Sum Test (one-sided alpha = 0.10).
Time frame: 168 Days
Pearson correlation coefficient (or Spearman, if appropriate
Time frame: 42 Days
Pearson correlation coefficient (or Spearman, if appropriate
Time frame: 84 Days
Pearson correlation coefficient (or Spearman, if appropriate
Time frame: 126 Days
Pearson correlation coefficient (or Spearman, if appropriate)
Time frame: 42 Days
Pearson correlation coefficient (or Spearman, if appropriate)
Time frame: 84 Days
Pearson correlation coefficient (or Spearman, if appropriate)
Time frame: 126 Days
Pearson correlation coefficient (or Spearman, if appropriate)
Time frame: 168 Days
Pearson correlation coefficient (or Spearman, if appropriate)
Time frame: PROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.
FACIT-TS-PS
Time frame: PROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.
PSS-10
Dana-Farber Cancer Institute
Other
Use of a Video-based, Personalized Web Page as a Complement to Standard Patient Education for Clinical Trial Participants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06580002
Adnexal Diseases, Blood Protein Disorders
Orange, California, United States
View Trial DetailsNCT06955910
Behavior, Behavioral Symptoms
Padova, Italy/Padova, Italy
View Trial DetailsNCT03345563
Bladder Cancer, Colon Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT04000880
Adnexal Diseases, Behavior
Birmingham, Alabama, United States
View Trial Details